Repeat Biopsy Decision-making

Repeat Biopsy Decision-Making is a clinical decision-making framework that determines the necessity, timing, and methodology of subsequent biopsy procedures in patients with inconclusive or high-risk findings during cervical or urologic cancer screening, distinguishing itself by integrating longitudinal biomarker trends, histopathological reassessment, and risk stratification models to optimize diagnostic accuracy and minimize unnecessary invasive interventions.

91

Publications

6.1K

Citations

549

Authors

208

Institutions

Publications per year

2017–2026

15

Authors

549

  1. SE
    Scott E. Eggener

    University of Chicago, United States

    3 publications · 687 citations

    3

    h-index

  2. MM
    Michael Marberger

    University of Vienna, Austria

    3 publications · 532 citations

    3

    h-index

  3. JT
    John T. Wei

    University of Michigan, United States

    3 publications · 401 citations

    3

    h-index

  4. MW
    Michael W. Kattan

    Cleveland Clinic, United States

    3 publications · 204 citations

    3

    h-index

  5. JL
    James L. Roberts

    Icahn School of Medicine at Mount Sinai, United States

    2 publications · 139 citations

    2

    h-index

1–5 of 549

Venues

  1. The Journal of Urology

    15 publications · 1.7K citations

    14

    h-index

  2. British Journal of Urology

    8 publications · 300 citations

    8

    h-index

  3. Urology

    6 publications · 750 citations

    6

    h-index

  4. PubMed

    Repository · 6 publications · 231 citations

    6

    h-index

  5. European Urology

    5 publications · 1.1K citations

    5

    h-index

1–5